These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3047719)

  • 21. Treatment with hypertonic dextrose and insulin in severe hyperkalaemia of immature infants.
    Lui K; Thungappa U; Nair A; John E
    Acta Paediatr; 1992 Mar; 81(3):213-6. PubMed ID: 1511193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Insulin Doses for the Treatment of Hyperkalemia in Patients with Renal Insufficiency.
    LaRue HA; Peksa GD; Shah SC
    Pharmacotherapy; 2017 Dec; 37(12):1516-1522. PubMed ID: 28976587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a Hyperkalemia Protocol Tailored to Glucose Concentration and Renal Function on Insulin-Induced Hypoglycemia in Patients with Low Pretreatment Glucose.
    Dybdahl D; Roberson T; Rasor E; Kline L; Pershing M
    J Emerg Med; 2024 Apr; 66(4):e421-e431. PubMed ID: 38462394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient.
    Adabala M; Jhaveri KD; Gitman M
    Nephrol Dial Transplant; 2010 Oct; 25(10):3439-42. PubMed ID: 20610525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemia as a complication of intravenous insulin to treat hyperkalemia in the emergency department.
    Scott NL; Klein LR; Cales E; Driver BE
    Am J Emerg Med; 2019 Feb; 37(2):209-213. PubMed ID: 29861377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of serum blood glucose monitoring after hyperkalaemia treatment using insulin and dextrose.
    Aljabri AM; Alsulami SA
    J Taibah Univ Med Sci; 2022 Feb; 17(1):82-86. PubMed ID: 35140569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide for the treatment of intentional insulin aspart overdose in a non-diabetic patient.
    Dewaal CM; McGillis E; Mink M; Lucyk S
    CJEM; 2018 Jul; 20(4):643-647. PubMed ID: 29202888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial.
    Chothia MY; Halperin ML; Rensburg MA; Hassan MS; Davids MR
    Nephron Physiol; 2014; 126(1):1-8. PubMed ID: 24576893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital? A randomised controlled trial.
    Moore C; Woollard M
    Emerg Med J; 2005 Jul; 22(7):512-5. PubMed ID: 15983093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing Hypoglycemia Following Treatment of Hyperkalemia in Hospitalized Patients.
    Boughton CK; Dixon D; Goble E; Burridge A; Cox A; Noble-Bell G; Bell C; Fidler B; Chudley J; Anderson C; Cavell G; Mustafa OG
    J Hosp Med; 2019 May; 14(5):284-287. PubMed ID: 30794138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient atrial fibrillation precipitated by hypoglycaemia: two case reports.
    Collier A; Matthews DM; Young RJ; Clarke BF
    Postgrad Med J; 1987 Oct; 63(744):895-7. PubMed ID: 3328849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood glucose response to rescue dextrose in hypoglycemic, critically ill patients receiving an insulin infusion.
    Murthy MS; Duby JJ; Parker PL; Durbin-Johnson BP; Roach DM; Louie EL
    Ann Pharmacother; 2015 Aug; 49(8):892-6. PubMed ID: 25986006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial.
    McTavish L; Corley B; Weatherall M; Wiltshire E; Krebs JD
    Diabet Med; 2018 Mar; 35(3):339-346. PubMed ID: 29285796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of hyperkalaemia.
    Maxwell AP; Linden K; O'Donnell S; Hamilton PK; McVeigh GE
    J R Coll Physicians Edinb; 2013; 43(3):246-51. PubMed ID: 24087806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of two potassium cocktail formulations for treatment of neonatal hyperkalemia.
    Oschman A; Gansen A; Kilbride H; Sandritter T
    Ann Pharmacother; 2011 Nov; 45(11):1371-7. PubMed ID: 22009997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Care Outcomes of Patients Receiving Hyperkalemia Treatment With Insulin in Acute Care Tertiary Hospital Emergency Department.
    Lim SH; Wahab SNBA; Ang SY; Teh MM; Aloweni F
    J Emerg Nurs; 2023 Jan; 49(1):99-108. PubMed ID: 36266095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial.
    Harris DL; Weston PJ; Signal M; Chase JG; Harding JE
    Lancet; 2013 Dec; 382(9910):2077-83. PubMed ID: 24075361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes.
    Amiel SA; Heller SR; Macdonald IA; Schwartz SL; Klaff LJ; Ruggles JA; Weyer C; Kolterman OG; Maggs DG
    Diabetes Obes Metab; 2005 Sep; 7(5):504-16. PubMed ID: 16050943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.